Royal Bank of Canada
YARW

Royal Bank of Canada’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Royal Bank of Canada’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49
Closed -$1.43K – 7742
2025
Q4 		$1K Hold
49
– – ﹤0.01% 7059
2025
Q3 		$1K Hold
49
– – ﹤0.01% 7036
2025
Q2 		$4K Hold
49
– – ﹤0.01% 6706
2025
Q1 		$4K Sell
49
-456
-90% -$56.1K ﹤0.01% 6438
2024
Q4 		$84K Buy
505
+456
+931% +$59.7K ﹤0.01% 5437
2024
Q3 		$5K Sell
49
-40
-45% -$3.79K ﹤0.01% 6518
2024
Q2 		$9K Sell
89
-3,418
-97% -$426K ﹤0.01% 6400
2024
Q1 		$538K Buy
3,507
+3,482
+13,928% +$375K ﹤0.01% 3921
2023
Q4 		$3K Sell
25
-19
-43% -$2.96K ﹤0.01% 6756
2023
Q3 		$9K Buy
44
+16
+57% +$3.49K ﹤0.01% 6471
2023
Q2 		$6K Buy
28
+24
+600% +$6.39K ﹤0.01% 6637
2023
Q1 		$1K Buy
4
+3
+300% +$539 ﹤0.01% 6943
2022
Q4 		$0 Hold
1
– – ﹤0.01% 7774
2022
Q3 		$0 Buy
+1
New +$320 ﹤0.01% 7919
2022
Q2 		– Hold
0
– – – 7752
2022
Q1 		– Sell
-1
Closed -$594 – 8048
2021
Q4 		$1K Hold
1
– – ﹤0.01% 7546
2021
Q3 		$1K Sell
1
-3
-75% -$5.82K ﹤0.01% 7511
2021
Q2 		$13K Hold
4
– – ﹤0.01% 6779
2021
Q1 		$24K Sell
4
-1
-20% -$7.25K ﹤0.01% 6331
2020
Q4 		$30K Buy
5
+4
+400% +$25.1K ﹤0.01% 5887
2020
Q3 		$8K Sell
1
-1
-50% -$5.83K ﹤0.01% 6017
2020
Q2 		$10K Hold
2
– – ﹤0.01% 5841
2020
Q1 		$16K Buy
+2
New +$31.4K ﹤0.01% 5644
2019
Q4 		– Hold
0
– – – 6312
2019
Q3 		– Hold
0
– – – 6527
2019
Q1 		– Hold
0
– -$1K – 7135
2018
Q4 		– Hold
0
– – – 6621
2018
Q3 		– Sell
-2
Closed -$61.7K – 6131
2018
Q2 		$60K Buy
+2
New +$77.7K ﹤0.01% 5073
2018
Q1 		– Hold
0
– – – 5847

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Royal Bank of Canada's YARW Position: Q1 2026 in Review

Royal Bank of Canada sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2026, closing a stake of 49 shares — an estimated $1.43K sold.

Royal Bank of Canada first reported a position in YARW in Q2 2018 and held it in 23 quarters. The position peaked at $538K in Q1 2024. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Royal Bank of Canada reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 49 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $1.43K.
  • Royal Bank of Canada first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2018 and held it in 23 quarters.
  • Royal Bank of Canada's Yarrow Bioscience, Inc. Common Stock position peaked at $538K in Q1 2024.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.